A Targeted and Orchestrated Signalling Matrix for Clinically Challenging Defects

A new material precisely positions multiple healing signals to coax stem cells into regenerating bone, targeting fractures that currently refuse to heal. The problem is that large bone defects—from trauma, non-healing fractures, or spinal surgeries—often defeat existing materials. Current grafts or scaffolds lack the right mix of biological instructions to make stem cells rebuild tissue properly. This project develops a multi-functional tissue matrix that delivers a tailored array of regenerative signals exactly where they are needed, rather than relying on a single, often insufficient, stimulus. If successful, the technology could change how surgeons treat the most challenging bone injuries. Instead of multiple operations or permanent disability, patients with critical-sized defects might receive a single implant that actively guides their own cells to fill the gap. The matrix is designed to be flexible—different signal combinations could be swapped in for other tissues—and its low-cost formulation reuses market-approved ingredients, which could speed regulatory approval and reduce manufacturing expense. For the NHS and other healthcare systems, this means fewer revision surgeries, shorter hospital stays, and lower long-term costs for a patient group that currently has few good options.